Analyst Ratings for Hi Tech Pharmacal (HITK)

HITK Rating Summary

  |   Expand Research on HITK
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 3.3 / 10   Percentile Rank: 20%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
8/27/2013 Standpoint Research N/A Downgrade Hold
(Buy)		 N/A
(N/A)		 35.21
(43.49)		 23.52% Details
1/5/2012 Canaccord
» Updated 12/7/2012		 N/A New Coverage Buy
(N/A)		 42.00
(42.00)		 39.45
(43.49)		 10.24% Details